Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy

Digestive Diseases and Sciences

Volumn 44, Issue 12, 1999, Pages 2508-2515

  Day, Richard ^a,b,c   Ilyas, Mohammad ^a,b,c   Daszak, Peter ^a,b,c   Talbot, Ian ^a,b,c   Forbes, Alastair ^a,b,c  

^a ST MARK S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

Heparin; Inflammatory bowel disease; Syndecan

Indexed keywords

GROWTH FACTOR RECEPTOR; HEPARAN SULFATE; HEPARIN; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; SYNDECAN;

ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DRUG MECHANISM; ENTERITIS; HEPARINIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0033388568     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026647308089     Document Type: Article

References (40)

1. 1. Gumbiner BM: Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 84:345-357, 1996
2. 2. Dippold W, Wittig B, Schwaeble W, Mayet W, Meyerzum Büshenfelde K-H: Expression of intercellular adhesion molecule-1 (ICAM-1, CD54) in colonic epithelial cells. Gut 34:1593-1597, 1993
3. 3. Jones SC, Banks RE, Haidar A, Gearing AJH, Hemingway IK, Ibbotson SH, Dixon MF, Axon ATR: Adhesion molecules in inflammatory bowel disease. Gut 36:724-730, 1995
4. 4. Koizumi M, King N, Lobb R, Benjamin C, Podolsky D: Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 103:840-847, 1992
5. 5. Jankowski J, Bedford F, Boulton R, Cruickshank N, Hall C, Elder J, Allan R, Forbes A, Kim Y, Wright N, Sanders D: Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis. Lab Invest 78:155-167, 1998
6. 6. Rosenberg W, Prince C, Kaklamanis L, Fox S, Jackson D, Simmons D, Chapman R, Trowell J, Jewell D, Bell J: Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet 345:1205-1209, 1995
7. 7. Dogan A, Wang Z, Spencer J: E-cadherin expression in intestinal epithelium. J Clin Pathol 48:143-146, 1995
8. 8. Hanhy A, Chinery R, Poulsom R, Playford R, Pignatelli M: Down regulation of E-cadherin in the reparative epithelium of the human gastrointestinal tract. Am J Pathol 148:723-729, 1996
9. 9. Hynes R: Integrins, a family of cell surface receptors. Cell 48:549-555, 1987
10. 10. Ruoslahti E: Proteoglycans in cell regulation. J Biol Chem 264:13369-13372, 1989
11. 11. Bernfield M, Hinkes M, Gallo R: Developmental expression of syndecans: Possible function and regulation. Development Suppl:205-212, 1993
12. 12. Saunders S, Jalkanen M, O'Farrell S, Bernfield M: Molecular cloning of syndecan, an integral membrane proteoglycan. J Cell Biol 108:1547-1556, 1989
13. 13. Sanderson R, Bernfield M: Molecular polymorphism of a cell surface proteoglycan: Distinct structures on simple and stratified epithelia. Proc Natl Acad Sci USA 85:9562-9566, 1988
14. 14. Sanderson R, Lalor P, Bernfield M: B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul 1:27-35, 1989
15. 15. Kato M, Bernfield M: Polymorphism of syndecan: a distinctive form on mesenchymal cells. J Cell Biol 109:320a, 1989
16. 16. Bernfield M, Kokenyesi R, Kato M, Hinkes M, Spring J, Gallo R, Lose E: Biology of the syndecans: A family of transmembrane heparan sulphate proteoglycans. Annu Rev Cell Biol 8:365-393, 1992
17. 17. Hayashi K, Hayashi M, Jalkanen M, Firestone J, Trelstad R, Bernfield M: Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscope study. J Histochem Cytochem 35:1079-1088, 1987
18. 18. Kato M, Saunders S, Nguyen H, Bernfield M: Loss of cell surface syndecan-1 causes epithelial cells to transform into anchorage-independent mesenchyme-like cells. Mol Biol Cell 6:559-576, 1995
19. 19. Day R, Hao X, Ilyas M, Daszak P, Talbot I, Forbes A: Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence. Virchows Arch 434:121-125, 1999
20. 20. Bhora FY, Dunkin BJ, Batzri S, Aly HM, Bass BL, Sidawy AN, Harmon JW: Effect of growth factors on cell proliferation and epithelization in human skin. J Surg Res 59:236-244, 1995
21. 21. New BA, Yeoman LC: Identification of basic fibroblast growth factor sensitivity and receptor ligand expression in human colon tumour cell lines. J Cell Physiol 150:320-326, 1992
22. 22. Rapraeger A, Krufka A, Olwin B: Requirement of heparan sulfate for bFGF-mediated fibroblast growth factor and myoblast differentiation. Science 252:1705-1708, 1991
23. 23. Steinfeld R, Van Den Berglie H, David G: Stimulation of fibroblast growth factor receptor-1 occupancy and signalling by cell surface-associated syndecans and glypican. J Cell Biol 133:405-416, 1996
24. 24. Yayon A, Klagsbrun M, Esko J, Leder P, Ornitz D: Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848, 1991
25. 25. Gaffney P, O'Leary J, Doyle C, Gaffney A, Hogan J, Smew F, Annis P: Response to heparin in patients with ulcerative colitis. Lancet 337:238-239, 1991
26. 26. Gaffney P, Doyle C, Gaffney A, Hogan J, Hayes D, Annis P: Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol 90:220-223, 1995
27. 27. Talbot I, Price A: Biopsy Pathology in Colorectal Disease. London, Chapman and Hall, 1987
28. 28. Norton A, Jordan S, Yeomans P: Brief high-temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 173:371-379, 1994
29. 29. Wijdenes J, Vooijs W, Clément C, Post J, Morard F, Vita N, Laurent P, Sun R, Klein B, Dore J: A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol 94:318-323, 1996
30. 30. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytoxicity assays. J Immunol Methods 65:56-63, 1983
31. 31. Kainulainen V, Nelimarkka L, Järveläinen H, Laato M, Jalkanen M, Elenius K: Suppression of syndecan-1 expression in endothelial cells by tumour necrosis factor-α. J Biol Chem 271:18759-18766, 1996
32. 32. Murch S, MacDonald T, Walker-Smith J, Levin M, Lionetti P, Klein N: Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet 341:711-714, 1993
33. 33. Szabo S, Kusstatscher S, Sakoulas G, Sandor Z, Vincze Á, Judus M: Growth factors: New "endogenous drugs" for ulcer healing. Scand J Gastroenterol 30(suppl 210):15-18, 1995
34. 34. Szabo S, Folkman J, Vattay P, Morales R, Pinkus G, Kato K: Accelerated healing of duodenal-ulcers by oral-administration of a mutein of basic fibroblast growth factor in rats. Gastroenterology 106:1106-1111, 1994
35. 35. Bousvaros A, Zurakowski D, Fishman S, Keogh K, Law T, Sun C, Leichtner A: Serum basic fibroblast growth factor in pediatric Crohn's disease - implications for wound healing. Dig Dis Sci 42:378-386, 1997
36. 36. Ohtani H, Nakamura S, Watanabe Y, Mizoi T, Saku T, Nagura H: Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Lab Invest 68:520-527, 1993
37. 37. Klagsbrun M, Baird A: A dual receptor system is required for basic fibroblast growth factor activity. Cell 67:229-231, 1991
38. 38. Dignass A, Tsunekawa S, Podolsky D: Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology 106:1254-1262, 1994
39. 39. Sanderson I, Leung K, Pearce F, Walker-Smith J: Lamina propria mast cells in biopsies from children with Crohn's disease. J Clin Pathol 39:279-283, 1986
40. 40. King T, Biddle W, Bhatia P, Moore J, Miner P: Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis. Dig Dis Sci 37:490-495, 1992 Please add symbol.